Last Posted: Jan 03, 2020
- Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications.
Tanner Julie-Anne et al. ClinicoEconomics and outcomes research : CEOR 2019 11779-787 - Knowledge of the Pharmacology of Antidepressants and Antipsychotics Yields Results Comparable With Pharmacogenetic Testing.
Macaluso Matthew et al. Journal of psychiatric practice 2018 24(6) 416-419 - Personalise antidepressant treatment for unipolar depression combining individual choices, risks and big data (PETRUSHKA): rationale and protocol.
Tomlinson Anneka et al. Evidence-based mental health 2019 Oct - A pharmacogenetic risk score for the evaluation of major depression severity under treatment with antidepressants.
Kanders Sofia H et al. Drug development research 2019 Oct - DNA Tests For Psychiatric Drugs Are Controversial But Some Insurers Are Covering Them
G Dangor, NPR, October 17, 2019 - Pharmacogenetics and Depression: A Critical Perspective.
Corponi Filippo et al. Psychiatry investigation 2019 Aug - Using Electronic Health Records and Machine Learning to Predict Postpartum Depression.
Wang Shuojia et al. Studies in health technology and informatics 2019 Aug 264888-892 - Non-REM Parasomnia: The Promise of Precision Medicine.
Erickson Joel et al. Sleep medicine clinics 2019 Sep 14(3) 363-370 - UnitedHealthcare To Cover Genetic Testing for Precision Medicine in Depression, Anxiety
Clinical Omics, August 2, 2019 - Development of Machine Learning Algorithms for Prediction of Sustained Postoperative Opioid Prescriptions After Total Hip Arthroplasty.
Karhade Aditya V et al. The Journal of arthroplasty 2019 Jun
.png)
No hay comentarios:
Publicar un comentario